Brent Saunders, Angel Investor

Brent is chairman and CEO of Bausch + Lomb, a world leader in eye care products and prescription pharmaceuticals. As CEO, he leads the company’s 13,000 employees in their mission to help people see better to live better. Brent has a proven track record as a senior executive and has built some of the most globally recognized consumer brands, including Botox, Claritin, and Coppertone. He has held executive leadership roles with multiple organizations in the health care sector, including Schering-Plough, Forest Laboratories, Actavis, and Allergan. He also previously served as president and CEO of Bausch + Lomb from 2010 to 2013. Brent excels at leading value-enhancing initiatives, overseeing more than $300B worth of mergers and acquisitions. Brent serves as chairman of the board of The Beauty Health Company and Roam. He is also an executive trustee at Mount Sinai Medical Center, a director at Arena AI, and a board advisor for Nextech. Brent is also an angel investor. His investments include Superform Labs (seed) and Osmind (series B).